ENTITY
Kyowa Kirin Co Ltd

Kyowa Kirin Co Ltd (4151 JP)

93
Analysis
Health Care • Japan
Kyowa Hakko Kirin Co.,Ltd. develops, manufactures, and markets pharmaceuticals. The Company's products include a protein produced by genetic recombination technology, an anti-anemia agent that attaches new sugar chains through partial modification of the amino acid sequence of human erythropoietin (EPO), and a glycoprotein, human erythropoietin.
more
Company Presentation • 09 Sep 2026 14:00

Investor presentation

Company Presentation • 03 Aug 2026 17:00

Q2 2026

Company Presentation • 07 May 2026 16:00

Q1 2026

Company Presentation • 10 Jan 2022 07:00

J.P. Morgan Healthcare Conference

Company Presentation • 09 Feb 2026 19:13

Q4 2025

x